glp-1 metabolism for Weight Loss and Diabetes The Impact of GLP1 Agonists

Prior pancreatitis, gallbladder disease, kidney problems, diabetic retinopathy, significant gastrointestinal symptoms, and use of insulin or sulfonylureas may require closer risk assessment rather than automatic exclusion

R.BennettG

Pancreatic Inflammation & Potential Pancreatic Damage While GLP-1 receptor agonists (e.g., Ozempic, Wegovy, Mounjaro) are widely used and carry established warnings for acute pancreatitis, extensive large-scale studies show the overall absolute risk remains very low, and long-term data indicates they do not increase the lifetime risk of pancreatic damage for most patients Pancreatitis is a known risk of GLP-1 drugs, but long-term consequences are still being studied

If directly asked about all substance use, peptides would arguably fall within that scope

That does not mean intranasal delivery is impossible or unexplored

The reporter of Cas12f with sgRNA for TTR was also constructed under the CMV promotor of pKLV2 vector, which has mCherry followed by T2A and TTR target sequence, further followed by the frameshifted two GFP sequences, IRES, and hygromycin resistance gene, resulting in pKLV2mCherry_TTR_GFPGFPv3